Restart Life Sciences (NMLSD)
OTHER OTC:NMLSD
Holding NMLSD?
Track your performance easily

Restart Life Sciences (NMLSD) Income Statement

20 Followers

Restart Life Sciences Income Statement

Last quarter (Q2 2024), Restart Life Sciences's total revenue was C$―, a decrease of ― from the same quarter last year. In Q2, Restart Life Sciences's net income was C$-90.58K. See Restart Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
----C$ 11.47KC$ 7.19K
Cost of Revenue
----C$ 9.74KC$ 5.57K
Gross Profit
----C$ 1.73KC$ 1.63K
Operating Expense
C$ 666.02KC$ 1.26MC$ 1.94MC$ 2.93MC$ 1.80MC$ 1.22M
Operating Income
C$ -666.02KC$ -1.26MC$ -1.94MC$ -2.93MC$ -1.80MC$ -1.22M
Net Non Operating Interest Income Expense
C$ 1.00C$ 2.00C$ 230.08KC$ -97.62KC$ -4.12KC$ -20.75K
Other Income Expense
C$ -37.44KC$ -36.08KC$ -7.69KC$ 151.84KC$ -23.44MC$ -196.68K
Pretax Income
C$ -628.58KC$ -1.22MC$ -2.47MC$ -2.68MC$ -25.23MC$ -1.40M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
-----C$ -93.96K
Net Income Common Stockholders
C$ -628.58KC$ -1.22MC$ -2.47MC$ -2.68MC$ -25.23MC$ -1.40M
Basic EPS
-C$ -0.01C$ -0.02C$ -0.02C$ -0.49C$ -0.16
Diluted EPS
-C$ -0.01C$ -0.02C$ -0.02C$ -0.49C$ -0.16
Basic Average Shares
C$ 590.49MC$ 146.76MC$ 136.56MC$ 111.10MC$ 51.15MC$ 8.00M
Diluted Average Shares
C$ 590.49MC$ 146.76MC$ 136.56MC$ 111.10MC$ 51.15MC$ 8.00M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 666.02KC$ 1.26MC$ 1.94M---
Interest Expense
------
Net Income From Continuing And Discontinued Operation
C$ -628.58KC$ -1.22MC$ -2.47MC$ -2.68MC$ -25.23MC$ -1.40M
Normalized Income
C$ -521.92KC$ -899.95KC$ -1.05MC$ -2.10MC$ 4.88MC$ -952.59K
EBIT
C$ -628.58KC$ -1.22MC$ -2.47MC$ -2.68MC$ -25.23MC$ -1.40M
EBITDA
C$ -625.96KC$ -1.22MC$ -2.46MC$ -2.68MC$ -1.79MC$ -1.39M
Currency in CAD

Restart Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis